Keynote Speakers and Invited Symposia/Workshops
Stephanie Clarke

Service de Neuropsychologie et de Neuroréhabilitation
CHUV (Centre Hospitalier Universitaire Vaudois)
Lausanne, Switzerland

Professor Stephanie Clarke, Past President of the World Federation of Neurorehabilitation, is Professor and Head of the Neuropsychology and Neurorehabilitation Clinic at the University Hospital, Lausanne, Switzerland. Her publications, more than 150 papers, focus on neuronal plasticity, its role in perception, learning and recovery from brain lesions. Since several years, she is strongly involved in scientific and professional societies.

No relevant financial or nonfinancial relationships exist.

John DeLuca

John DeLuca, PhD, is the Senior Vice President for Research and Training at Kessler Foundation, a Professor in the Department of Physical Medicine & Rehabilitation, and the Department of Neurology at Rutgers, New Jersey Medical School. He is board certified in Rehabilitation Psychology by the American Board of Professional Psychology. Dr. DeLuca is internationally known for his research on disorders of memory and information processing in a variety of clinical populations including: multiple sclerosis, traumatic brain injury, aneurysmal subarachnoid hemorrhage, and Chronic Fatigue Syndrome. Dr. DeLuca has published over 300 articles and book chapters in these areas, has edited 5 books in neuropsychology, neuroimaging and rehabilitation, and is a co-editor for the “Encyclopedia of Clinical Neuropsychology.” He has received over 32 million dollars in grant support for his research. Dr. DeLuca's most recent research ventures include the cerebral mapping of human cognitive processes using functional neuroimaging, as well as the development of research-based techniques to improve cognitive impairment.

Presenter received grant funding from the National MS Society.

John-Dylan Haynes

John-Dylan Haynes obtained his Diploma in Psychology in 1997 and his PhD in Biology in 2003 from the University of Bremen. This was followed by postdoctoral research positions at the University of Plymouth, the Otto-von-Guericke-University Magdeburg and the Wellcome Center for Imaging Neuroscience at the University College London. In 2005 he started his own research group at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig. In 2006 he became Professor for Theory and Analysis of Large Scale Brain Signals at the Charité - Universitätsmedizin Berlin and at the Bernstein Center for Computational Neuroscience Berlin. Since 2009 he is Founding Director of the the Berlin Center for Advanced Neuroimaging (BCAN).

No relevant financial or nonfinancial relationships exist.

Tedd Judd

Tedd Judd, PhD, ABPP-CN, is a clinical and forensic neuropsychologist, and cultural generalist with 38 years of experience. He has evaluated clients from about 90 countries and has taught neuropsychology in 24 countries. He is Past President of the Hispanic Neuropsychological Society. He teaches a practicum in non-English cross-cultural psychological assessment and is the academic co-director of Central America’s first Master’s degree in neuropsychology at the Universidad del Valle, Guatemala.

No relevant financial or nonfinancial relationships exist.

Tomas Paus

Dr. Paus is a Distinguished Senior Scientist and the Director of Population Neuroscience & Developmental Neuroimaging Program at the Holland Bloorview Kids Rehabilitation Hospital, and Professor of Psychology and Psychiatry at the University of Toronto.

During the first 20 years of his scientific pursuits, he worked on functional and structural organization of the human brain using a variety of approaches including studies of patients with brain lesions, patients with psychiatric disorders, functional and structural neuroimaging, and brain stimulation.

In the last 15+ years, his work integrates epidemiology, neuroscience and genetics – through a new discipline of population neuroscience - in the pursuit of knowledge relevant for child and youth brain health. This research draws on data acquired in a number of cohorts based in North and South America and Europe.

The work published by Dr. Paus and his colleagues has been well received by peers, being cited in over 40,000 publications. In 2013, Springer published his book “Population Neuroscience”. Dr. Paus received the Royal Society Wolfson Merit Award, Gold Medal of the Masaryk University, and is an elected member of the International Neuropsychology Symposium. He serves as Associate Editor of the Human Brain Mapping and Social Neuroscience, is a member of several Scientific Advisory Boards in Europe and North America, and chairs the Behavioural Science 2 (Clinical) committee of the Canadian Institutes of Health Research.

No relevant financial or nonfinancial relationships exist.

Josef Vymazal

Professor Josef Vymazal is the Head of the Department of Radiology and a Full Professor at Charles University in Prague, Czech Republic. He received his MD and PhD from Charles University in 1986 and 1989, respectively. He publishes extensively in national and international scientific journals on a variety of issues related to advances and clinical applications of neuroimaging, and has authored multiple texts on neuroimaging techniques.

Presenter received consulting fees from Novocvize and speaking fee from Bracco.

Kathleen A. Welsh-Bohmer

Professor & Chief of Medical Psychology
Departments of Psychiatry and Neurology
Duke University Health System &
Director of Alzheimer’s Disease Interventional Trials
Duke Clinical Research Institute (DCRI)

Dr. Kathleen Welsh-Bohmer is a Professor of Psychiatry and Neurology at Duke University as well as the Chief of Medical Psychology Clinical Professional Unit, the professional home for the over 200 academic psychologists within Duke Health System. Clinically trained as a neuropsychologist, her research activities have been focused around developing effective prevention and treatment strategies to delay the onset of cognitive disorders occurring in later life. She was the Principal Investigator of the Cache County Memory Study (NIA AG11380; 2002-2013), an epidemiological study of an exceptionally long-lived population that established key environmental modifiers affecting Alzheimer’s disease onset and progression. Since 2006 she has directed the Joseph and Kathleen Bryan Alzheimer’s Center in the Department of Neurology, where she leads a large multidisciplinary team focused on discovering the biological basis of Alzheimer’s disease and developing methods to enhance early diagnosis and speed drug discovery. Since 2011, she has been leading the neuropsychology scientific operations of a Phase III global clinical trial to delay the onset of Alzheimer’s disease entitled the “TOMMORROW” study (Takeda Pharmaceutical Company funded). Most recently, she was appointed to lead Alzheimer’s Disease Therapeutic Trials within the Duke Clinical Research Institute, a large Academic Clinical Research Organization. The methods her team have developed in collaboration with public and private partnerships fill an information void and have important implications for accelerating global clinical trials in Alzheimer’s disease prevention and for optimizing brain health across the lifespan.

Presenter received grant funding and has been a consultant for Takeda Pharmaceutical Company.

Keith Owen Yeates

Keith Owen Yeates, Ph.D., R.Psych., ABPP-CN, is the Ronald and Irene Ward Chair in Pediatric Brain Injury and Professor in the Departments of Psychology, Pediatrics, and Clinical Neurosciences at the University of Calgary, in Alberta, Canada. He leads the University’s Integrated Concussion Research Program. Dr. Yeates has served as President of the Society of Clinical Neuropsychology of the American Psychological Association, and is currently President of the International Neuropsychological Society.

Presenter receives book royalties from Guilford Press and Cambridge University Press.

Copyright © 2017 - GUARANT International spol. s r.o. All rights reserved. Powered by APPTIDE.